Fundraising Fox
Atraverse Medical
Chicago, US · Founded 2022 · Delaware corporation · 36 employees on LinkedIn · 2 known investors
Find your way into Atraverse Medical
Sign up to see every warm intro you have to Atraverse Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Atraverse Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Atraverse Medical develops transseptal access devices used in cardiac catheterization procedures, with products compatible with sheaths and systems from Abbott, Biosense Webster, Medtronic, and Boston Scientific. The company targets the interventional cardiology and electrophysiology market.
Founders & leadership
Atraverse Medical was founded in 2022 by Steven Mickelsen.
SM
Steven MickelsenFounder · Board MemberSteven Mickelsen is Director at Atraverse Medical, where he works on transseptal access technologies for cardiac catheterization procedures. He has focused on developing medical devices for heart rhythm and cardiovascular conditions, with experience spanning preclinical development and clinical cardiology.
JR
John R SlumpCEO/President & Co-Founder2022–2026John R Slump is an executive and director at Atraverse Medical, which develops flexible transseptal access technologies for left-heart catheter procedures. He has held leadership roles at multiple medical device companies including those later acquired by Integra, Haemonetics, and Boston Scientific.
Board
Investors · 2
Reported raises · per SEC filings
Form D private placements$33.1M disclosed across 5 rounds · 2023–2025
▶$8.6MraisedMay 2025 · 41 investors · Other Health CareRule 506(b)
▶$8.6MraisedMay 2025 · 41 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric D. SauterExecutive Officer, Director, Promoter
- John R. SlumpExecutive Officer, Director, Promoter
- Steven MickelsenExecutive Officer, Director, Promoter
- Offering amount
- $10M
- Amount sold
- $8.6M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$15MraisedFeb 2025 · 1 investors · Other Health CareRule 506(b)
▶$15MraisedFeb 2025 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric D. SauterExecutive Officer, Director, Promoter
- John R SlumpExecutive Officer, Director, Promoter
- Steven R. MickelsenExecutive Officer, Director, Promoter
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$4.1MraisedAug 2024 · 33 investors · Other Health CareRule 506(b)
▶$4.1MraisedAug 2024 · 33 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric SauterDirector
- Steven MickelsenDirector
- John R SlumpExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $4.1M
- Minimum investment
- $10K
- Proceeds to insiders
- $750K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$5MraisedNov 2023 · 32 investors · Other Health CareRule 506(b)
▶$5MraisedNov 2023 · 32 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric SauterDirector
- John R SlumpExecutive Officer, Director
- Steven MickelsenDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $100K
- Proceeds to insiders
- $1M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$400KraisedNov 2023 · 1 investors · Other Health CareRule 506(b)
▶$400KraisedNov 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John R SlumpExecutive Officer, Director
- Eric SauterDirector
- Steven MickelsenDirector
- Offering amount
- $3M
- Amount sold
- $400K
- Minimum investment
- $100K
- Proceeds to insiders
- $500K
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Atraverse Medical went on to found or lead other companies.
In the news
Frequently asked questions
- What does Atraverse Medical do?
- Atraverse Medical develops transseptal access devices used in cardiac catheterization procedures, with products compatible with sheaths and systems from Abbott, Biosense Webster, Medtronic, and Boston Scientific. The company targets the interventional cardiology and electrophysiology market.
- Who founded Atraverse Medical?
- Atraverse Medical was founded by Steven Mickelsen in 2022.
- Who are Atraverse Medical's investors?
- Atraverse Medical's investors include Band of Angels, MEDA Angels.
- How much funding has Atraverse Medical raised?
- Atraverse Medical has disclosed $33.1M raised across 5 rounds.
- Where is Atraverse Medical headquartered?
- Atraverse Medical is headquartered in Chicago, US.